Lydia Linasari Sinarta, I Wayan Artana Putra
Abstract: Coronavirus disease 2019 (COVID-19) is a disease caused by infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV2). This disease has become epidemic almost all over the world and the number is still increasing at this time. This infection is mainly transmitted through droplets containing the virus. The clinical spectrum caused by these infections is very broad, from asymptomatic to critical and even death. Clinical manifestations also vary greatly, although symptoms of fever and respiratory disorders are the main symptoms. Symptoms tend to be more severe in cases with cardiorespiratory or metabolic comorbidity. In the obstetric field, the impact of COVID-19 is still not very clear. There is a possibility that the virus infection will cause bad outcomes, both in the maternal and fetus. One possible maternal impact is complications of postpartum hemorrhage because in theory COVID-19 can also cause thrombocytopenia. However, data supporting this are still very limited. Specific management recommendations for post-partum hemorrhage in the COVID-19 era do not yet exist. More aggressive prophylaxis of bleeding is possible to reduce the risk of this bleeding. In general, the principle of management may be no different, but the use of personal protective equipment, isolation rooms, and contact minimization remain consistent with obstetric procedures in general.
Keywords: COVID-19, postpartum hemorrhage, management